Liver Impairment and Hematological Changes in Patients with Chronic Hepatitis C and COVID-19: A Retrospective Study after One Year of Pandemic

被引:29
作者
Cerbu, Bianca [1 ]
Pantea, Stelian [2 ]
Bratosin, Felix [1 ]
Vidican, Iulia [1 ]
Turaiche, Mirela [1 ]
Frent, Stefan [3 ]
Borsi, Ema [4 ]
Marincu, Iosif [1 ]
机构
[1] Victor Babes Univ Med & Pharm, Dept Infect Dis, Timisoara 300041, Romania
[2] Victor Babes Univ Med & Pharm, Surg Clin Dept 2, Timisoara 300041, Romania
[3] Victor Babes Univ Med & Pharm, Ctr Res & Innovat Precis Med Resp Dis, Dept Pulmonol, Timisoara 300041, Romania
[4] Victor Babes Univ Med & Pharm, Dept Internal Med Hematol, Timisoara 300041, Romania
来源
MEDICINA-LITHUANIA | 2021年 / 57卷 / 06期
关键词
COVID-19; SARS-CoV-2; infection; hepatitis C virus; liver impairment; mortality risk;
D O I
10.3390/medicina57060597
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives: The COVID-19 pandemic is an ongoing public health emergency. Patients with chronic diseases are at greater risk for complications and poor outcomes. The objective of this study was to investigate the liver function abnormalities and clinical outcomes in patients with COVID-19 and chronic hepatitis C. Materials and Methods: This retrospective, single-center study was conducted on a cohort of 126 patients with a history of hepatitis C, confirmed with COVID-19 between 01 April 2020 and 30 December 2020. Several clinical outcomes were compared between patients with active and non-active HCV infection, and the risks of liver impairment and all-cause mortality in active HCV patients were analyzed using a multivariate logistic regression model. Results: Among 1057 patients under follow-up for chronic HCV infection, 126 (11.9%) were confirmed with COVID-19; of these, 95 (75.4%) were under treatment or achieved SVR, while in the other 31 (24.6%), we found active HCV replication. There was a significantly higher proportion of severe COVID-19 cases in the active HCV group as compared to the non-active HCV group (32.2 vs. 7.3%, p < 0.001). Multivariate analysis showed that age, sex, alanine aminotransferase, C-reactive protein, procalcitonin, and HCV viral load were significant independent risk factors for liver impairment and all-cause mortality. The length of stay in hospital and intensive care unit for COVID-19 was significantly higher in patients with active HCV infection (p-value < 0.001), and a higher proportion of these patients required mechanical ventilation. Conclusions: Active HCV infection is an independent risk factor for all-cause mortality in COVID-19 patients.
引用
收藏
页数:9
相关论文
共 23 条
[1]   Comparison of mortality risk in patients with cirrhosis and COVID-19 compared with patients with cirrhosis alone and COVID-19 alone: multicentre matched cohort [J].
Bajaj, Jasmohan S. ;
Garcia-Tsao, Guadalupe ;
Biggins, Scott W. ;
Kamath, Patrick S. ;
Wong, Florence ;
McGeorge, Sara ;
Shaw, Jawaid ;
Pearson, Meredith ;
Chew, Micheal ;
Fagan, Andrew ;
Rodriguez, Randolph de la Rosa ;
Worthington, Janelle ;
Olofson, Amy ;
Weir, Vanessa ;
Trisolini, Calvin ;
Dwyer, Sarah ;
Reddy, K. Rajender .
GUT, 2021, 70 (03) :531-536
[2]   COVID-19 and drug-induced liver injury: a problem of plenty or a petty point? [J].
Boeckmans, Joost ;
Rodrigues, Robim M. ;
Demuyser, Thomas ;
Pierard, Denis ;
Vanhaecke, Tamara ;
Rogiers, Vera .
ARCHIVES OF TOXICOLOGY, 2020, 94 (04) :1367-1369
[3]  
Chai X, 2020, bioRxiv, DOI [10.1101/2020.02.03.931766, 10.1101/2020.02.03.931766]
[4]   Liver injury in the era of COVID-19 [J].
Cichoz-Lach, Halina ;
Michalak, Agata .
WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (05) :377-390
[5]  
European Centre for Disease Prevention and Control, 2020, HEP C ANN EP REP 201
[6]   Clinical Features of Patients Infected With Coronavirus Disease 2019 With Elevated Liver Biochemistries: A Multicenter, Retrospective Study [J].
Fu, Yu ;
Zhu, Rui ;
Bai, Tao ;
Han, Ping ;
He, Qin ;
Jing, Mengjia ;
Xiong, Xiaofeng ;
Zhao, Xi ;
Quan, Runze ;
Chen, Chaoyue ;
Zhang, Ying ;
Tao, Meihui ;
Yi, Jianhua ;
Tian, Dean ;
Yan, Wei .
HEPATOLOGY, 2021, 73 (04) :1509-1520
[7]   Clinical Characteristics of Covid-19 in New York City [J].
Goyal, Parag ;
Choi, Justin J. ;
Safford, Monika M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (24) :2372-2374
[8]   Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity [J].
Grove, Joe ;
Huby, Thierry ;
Stamataki, Zania ;
Vanwolleghem, Thomas ;
Meuleman, Philip ;
Farquhar, Michelle ;
Schwarz, Anne ;
Moreau, Martine ;
Owen, James S. ;
Leroux-Roels, Geert ;
Balfe, Peter ;
McKeating, Jane A. .
JOURNAL OF VIROLOGY, 2007, 81 (07) :3162-3169
[9]   Abnormal Liver Tests in COVID-19: A Retrospective Observational Cohort Study of 1,827 Patients in a Major US Hospital Network [J].
Hundt, Melanie A. ;
Deng, Yanhong ;
Ciarleglio, Maria M. ;
Nathanson, Michael H. ;
Lim, Joseph K. .
HEPATOLOGY, 2020, 72 (04) :1169-1176
[10]   Chronic liver disease is not associated with severity or mortality in Coronavirus disease 2019 (COVID-19): a pooled analysis [J].
Lippi, Giuseppe ;
de Oliveira, Maria Helena Santos ;
Henry, Brandon Michael .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (01) :114-115